KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cvs Health (CVS) Operating Expenses (2016 - 2025)

Cvs Health's Operating Expenses history spans 17 years, with the latest figure at $103.6 billion for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 8.64% year-over-year to $103.6 billion, compared with a TTM value of $397.4 billion through Dec 2025, up 9.09%, and an annual FY2025 reading of $397.4 billion, up 9.09% over the prior year.
  • Operating Expenses for Q4 2025 was $103.6 billion at Cvs Health, down from $106.1 billion in the prior quarter.
  • The five-year high for Operating Expenses was $106.1 billion in Q3 2025, with the low at $8.9 billion in Q1 2021.
  • Average Operating Expenses over 5 years is $82.1 billion, with a median of $85.9 billion recorded in 2023.
  • Year-over-year, Operating Expenses soared 721.35% in 2022 and then rose 1.17% in 2023.
  • Tracing CVS's Operating Expenses over 5 years: stood at $74.3 billion in 2021, then grew by 7.98% to $80.2 billion in 2022, then increased by 12.79% to $90.4 billion in 2023, then increased by 5.42% to $95.3 billion in 2024, then grew by 8.64% to $103.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Operating Expenses are $103.6 billion (Q4 2025), $106.1 billion (Q3 2025), and $96.5 billion (Q2 2025).